Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
451.87
401.32
371.40
361.09
364.13
281.09
421.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
451.87
401.32
371.40
361.09
364.13
281.09
421.66
Raw Material Cost
188.78
198.49
160.86
162.70
198.61
118.95
130.62
Purchase of Finished goods
22.84
16.72
35.82
16.13
18.53
52.02
154.07
(Increase) / Decrease In Stocks
-1.68
-15.15
-12.52
12.12
-24.42
-9.83
3.19
Employee Cost
64.35
54.05
46.78
41.52
36.68
31.76
25.82
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
104.49
71.39
61.88
65.23
70.72
36.59
33.54
Total Expenditure (Excl Depreciation)
378.78
325.51
292.82
297.70
300.12
229.49
347.23
Operating Profit (PBDIT) excl Other Income
73.09
75.81
78.58
63.39
64.01
51.60
74.43
Other Income
55.63
9.16
17.72
9.16
13.27
9.78
15.01
Operating Profit (PBDIT)
128.72
84.97
96.30
72.55
77.28
61.38
89.44
Interest
8.51
5.36
2.94
4.02
2.07
2.32
1.94
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
120.21
79.61
93.36
68.53
75.21
59.06
87.50
Depreciation
16.46
13.83
12.58
9.15
8.63
8.60
6.27
Profit Before Tax
103.74
65.78
80.78
59.39
66.57
50.46
81.22
Tax
30.79
17.98
23.36
15.91
18.38
12.20
16.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
72.95
47.80
57.42
43.48
48.19
38.26
64.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
72.95
47.80
57.42
43.48
48.19
38.26
64.23
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.66
-2.84
-0.43
-3.91
-2.67
-1.56
0.54
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
70.29
44.96
56.99
39.57
45.52
36.70
64.77
Equity Capital
10.56
10.51
10.44
10.37
10.35
10.31
10.31
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
843.36
0.00
0.00
Earnings per share (EPS)
6.66
4.28
5.46
3.82
4.4
3.56
6.28
Diluted Earnings per share
6.58
4.22
5.37
3.75
4.3
3.48
6.28
Operating Profit Margin (Excl OI)
16.18%
18.89%
21.16%
17.56%
17.58%
18.36%
17.65%
Gross Profit Margin
26.6%
19.84%
25.14%
18.98%
20.65%
21.01%
20.75%
PAT Margin
16.14%
11.91%
15.46%
12.04%
13.23%
13.61%
15.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 12.60% vs 8.06% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is 56.34% vs -21.11% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is -3.59% vs -3.53% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 58.77% vs 82.31% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Bliss GVS Pharma With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
451.87
432.49
19.38
4.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
451.87
432.49
19.38
4.48%
Raw Material Cost
188.78
269.74
-80.96
-30.01%
Purchase of Finished goods
22.84
0.00
22.84
(Increase) / Decrease In Stocks
-1.68
-3.06
1.38
45.10%
Employee Cost
64.35
68.68
-4.33
-6.30%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
104.49
42.04
62.45
148.55%
Total Expenditure (Excl Depreciation)
378.78
377.40
1.38
0.37%
Operating Profit (PBDIT) excl Other Income
73.09
55.09
18.00
32.67%
Other Income
55.63
8.88
46.75
526.46%
Operating Profit (PBDIT)
128.72
63.97
64.75
101.22%
Interest
8.51
2.07
6.44
311.11%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
120.21
61.90
58.31
94.20%
Depreciation
16.46
15.05
1.41
9.37%
Profit Before Tax
103.74
46.85
56.89
121.43%
Tax
30.79
11.38
19.41
170.56%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
72.95
35.46
37.49
105.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
72.95
35.46
37.49
105.72%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-2.66
0.00
-2.66
Other related items
0.00
0.00
0.00
Consolidated Net Profit
70.29
35.46
34.83
98.22%
Equity Capital
10.56
10.45
0.11
1.05%
Face Value
1.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.66
16.97
-10.31
-60.75%
Diluted Earnings per share
6.58
16.72
-10.14
-60.65%
Operating Profit Margin (Excl OI)
16.18%
12.74%
0.00
3.44%
Gross Profit Margin
26.60%
14.31%
0.00
12.29%
PAT Margin
16.14%
8.20%
0.00
7.94%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 451.87 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 12.60% vs 8.06% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 70.29 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 56.34% vs -21.11% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 73.09 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -3.59% vs -3.53% in Sep 2024
Half Yearly - Interest
Interest 8.51 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 58.77% vs 82.31% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.18%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
